Avelos Therapeutics is a precision medicine company that develops next-generation targeted oncology medicines. Their primary focus is on synthetic lethality, cell cycle regulation, undruggable cancer targets, and DNA damage response. They aim to provide solutions to high unmet needs in the field of oncology, with present and future applications. Avelos Therapeutics is currently in the clinical stage and is committed to finding and creating innovative targeted therapeutics.